LexisNexis® Legal Newsroom
11th Circuit: MDL Plaintiffs Didn’t Lay Foundation For Admitting Accutane Study

ATLANTA — (Mealey’s) The 11th Circuit U.S. Court of Appeals on May 7 affirmed summary judgment in six federal Accutane cases, finding that the plaintiffs had not shown that their excluded causation expert relied on a new study linking the acne drug to inflammatory bowel disease (IBD) ( In...

$13.6 Million Accutane Judgment Reversed For New Trial To Include 'Numbers' Evidence

TRENTON, N.J. - (Mealey's) A New Jersey appeals court panel on Aug. 5 vacated a $13.6 million Accutane judgment after ruling that the trial judge restricted defendant Hoffman-La Roche Inc.'s use of numbers comparing the total number of Accutane users and the population background rate of inflammatory...

Weitz & Luxenberg Attorney Ellen Relkin To Co-Chair Major DePuy Litigation

NEW YORK - Weitz & Luxenberg has announced that Ellen Relkin, one of the leading attorneys in its Defective Medicines and Medical Devices Litigation Unit, has been selected to co-chair the Plaintiff's Executive Committee acting on behalf of the claimants in the DePuy Orthopaedics Inc. ASR Hip...

New Jersey Jury Awards $2M In 1 Accutane Case, Finds For Defense In 2 Others

ATLANTIC CITY, N.J. - (Mealey's) A New Jersey state court jury on April 8 awarded a plaintiff $2.1 million after finding that Hoffman-La Roche Inc.'s acne drug Accutane was a substantial factor in causing her inflammatory bowel disease (IBD) and that the company failed to adequately warn her...

Hung Jury Results In Mistrial In New Jersey Accutane Case Alleging Bowel Injury

ATLANTIC CITY, N.J. - A New Jersey state court Accutane trial ended Dec. 22 with a hung jury, a source told Mealey Publications ( Chetan P. Tanna, et al. v. Hoffman-La Roche Inc. , No. ATL-L-3366-04, N.J. Super., Atlantic Co.). The source said that Judge Carol E. Higbee of the Atlantic County Superior...

N.J. High Court Says State Discovery Rule Not Foreclosed By Product Liability Law

TRENTON, N.J. - (Mealey's) New Jersey's discovery rule is not foreclosed by a presumption in the state's product liability law that Food and Drug Administration-approved warnings are adequate, the state Supreme Court ruled 5-1 on Feb. 27 in an Accutane case now headed for retrial ( Kamie...

$11.8 Million New Jersey Accutane Verdicts Vacated By Florida Ruling On Proximate Causation

TRENTON, N.J. - (Mealey's) A New Jersey state appeals panel on Aug. 7 vacated an $11.8 million Accutane verdict after finding that under controlling Florida case law, three plaintiffs had not established that a failure to warn about the risk of inflammatory bowel disease (IBD) by defendant Hoffman...

New Jersey Accutane Judge Denies Defendant Roche's Motion To Recuse For Bias

ATLANTIC CITY, N.J. - (Mealey's) The judge overseeing New Jersey's Accutane litigation on Feb. 13 denied a motion by defendant Hoffman-La Roche Inc. to recuse, refuting allegations that she is biased in favor of plaintiffs and stating that in this litigation, defense counsel are "less respectful...

New Jersey Jury Awards $1.58M In Retrial Of Accutane Bowel Injury Case

ATLANTIC CITY, N.J. — (Mealey’s) A New Jersey state court jury on March 11 found that Hoffman-La Roche failed to adequately warn that its former acne drug Accutane could cause ulcerative colitis and awarded the plaintiff $1,587,928 for past medical expenses and for pain and suffering ( Kamie...

$2M N.J. Accutane Verdict Reversed, 2 Defense Verdicts Affirmed On Appeal

TRENTON, N.J. — (Mealey’s) A New Jersey appeals panel on Aug. 4 vacated a $2,125,617 Accutane bowel injury verdict and affirmed defense verdicts in two other cases tried at the same time ( Gillian Gaghan v. Hoffman-La Roche Inc., et al. , Nos. A-2717-11T2, A-3211-11T2 and A-3217-11T2, N.J...

N.J. Accutane Judge: Post-2002 Warnings Of Bowel Injury Are Adequate Under Law

ATLANTIC CITY, N.J. — (Mealey’s) A judge overseeing New Jersey’s Accutane litigation on April 2 granted summary judgment to Accutane manufacturer Hoffman-La Roche after finding that as a matter of law, the drug’s post-April 2002 warnings about inflammatory bowel disease (IBD)...

$25 Million Accutane Verdict Vacated On Appeal In New Jersey On Law Choice, Limitations

TRENTON, N.J. — (Mealey’s) A New Jersey appeals panel on Aug. 11 vacated a $25 million Accutane bowel injury verdict after finding that Alabama’s statute of limitations applied, rather than New Jersey’s, and that the plaintiff’s claim was time-barred ( Andrew McCarrell v...